Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Anika Therapeutics (ANIK) over the last 6 years, with Dec 2024 value amounting to $2.1 million.

  • Anika Therapeutics' Amortizatization of Intangibles fell 15.53% to $495,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 38.67%. This contributed to the annual value of $2.1 million for FY2024, which is 72.38% down from last year.
  • Latest data reveals that Anika Therapeutics reported Amortizatization of Intangibles of $2.1 million as of FY2024, which was down 72.38% from $7.8 million recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Amortizatization of Intangibles registered a high of $7.8 million during FY2021, and its lowest value of $2.1 million during FY2024.
  • In the last 3 years, Anika Therapeutics' Amortizatization of Intangibles had a median value of $7.8 million in 2023 and averaged $5.9 million.
  • In the last 5 years, Anika Therapeutics' Amortizatization of Intangibles skyrocketed by 526.04% in 2020 and then crashed by 72.38% in 2024.
  • Anika Therapeutics' Amortizatization of Intangibles (Yearly) stood at $7.4 million in 2020, then climbed by 6.18% to $7.8 million in 2021, then declined by 0.69% to $7.8 million in 2022, then remained steady at $7.8 million in 2023, then tumbled by 72.38% to $2.1 million in 2024.